DeepTek vs Qure.ai
Updated October 16, 2026
Imaging programs that want AI help reading chest X-rays often compare DeepTek and Qure.ai. Both are India-founded companies with FDA-cleared chest algorithms, but Qure.ai also covers CT and head scans and moves urgent studies up the list, while DeepTek pairs its chest AI with a platform for running other radiology tools. Programs buying one strong chest product and programs buying broad triage end up in different places.
Our analysts compared DeepTek and Qure.ai on study range, chest X-ray depth, urgent flagging, PACS rollout, and company scale, using the HIR review of each company and Qure.ai's newsroom. In the following sections, we compare them across one table, describe the imaging program each suits, and note Qure.ai's latest clearance.
DeepTek vs Qure.ai at a glance, October 2026
| What buyers weigh | DeepTek | Qure.ai |
|---|---|---|
| Pricing model | Software licenses for FDA-cleared chest X-ray AI and radiology AI platform modules. | Radiology AI licenses per study or for the whole organization, quoted by imaging type and volume. |
| What drives cost | The number of sites, scan volume, modules, and whether it runs in the cloud or on your own servers. | Study volume by imaging type, which algorithms you buy, regions covered, and support. |
| Range of studies | Chest X-ray comes first, with Augmento for wider radiology workflows, and platform depth scores 7.1. | Chest X-ray, CT, and head scan findings, with product breadth scored 7.4. Higher score |
| Chest X-ray | Chest X-ray AI is its core product, and it scores 7.3 on chest X-ray use. | Chest X-ray triage is one of its main FDA-cleared products. |
| Flagging urgent findings | Flagged chest X-ray findings go to a queue, and their value depends on whether radiologists trust them. | Algorithms move critical findings to the top of the worklist, and detection outcomes score 7.5. Clear edge |
| Rollout in PACS | PACS and workflow rollout scores 6.8. | PACS and RIS integration with clinical validation scores 7.1. Higher score |
| Time to full value | Not published | About 4 to 8 months |
| What you need first | A clinical owner in radiology, plus imaging IT. | An owner for the PACS and RIS connection. |
| Deal-breaker | There is no imaging IT or clinical owner. | You have no imaging volume. |
| Pricing clarity score | 6.9 | 7.0 |
| HIR overall score | 7.1, Recommend. | 7.4, Recommend. Higher score |
| Best for | Imaging programs that want FDA-cleared chest X-ray AI and a radiology AI platform without buying a broad triage suite first. | Hospitals and imaging networks that need AI triage for chest X-ray, CT, and emergency findings. |
| Not a fit for | Programs without chest radiograph volume. | Clinics with no imaging volume and no PACS integration path. |
Which fits which buyer
Decide whether you need chest X-ray alone or wider triage.
Choose DeepTek if
- Chest X-ray is your main AI need and you want a lighter first purchase.
- You want a platform to run AI tools from several vendors.
- You have the chest radiograph volume to justify it.
Choose Qure.ai if
- You want triage across chest X-ray, CT, and head scans.
- Critical findings should move to the top of the worklist automatically.
- You want a vendor with deployments in many countries.
What buyers say
“Qure.ai for cxr was awful. Made an image in PACs highlighting what it saw that all clinicians and patients could see. Overcalled every opacity, “fibrosis” and pneumothorax.” aznwand01 · r/radiologyAI · Apr 15, 2026, source
Verdict
Qure.ai scores higher and suits hospitals that want broad, FDA-cleared triage across modalities. DeepTek fits programs focused on chest X-ray that also want a platform for other vendors' AI.
Clinics without imaging volume or a PACS path should wait.
Where the two tools are headed in 2027 and beyond
Qure.ai: Qure.ai announced FDA clearance for qXR-Detect, which flags findings across six regions of a chest X-ray, on February 26, 2026.
Ask both for local validation results on your own scanner mix.
Methodology
Each row comes from the HIR reviews of DeepTek and Qure.ai, scored under the HIR method, and from each vendor's public pricing where it exists. Any published price for DeepTek or Qure.ai was checked on that vendor's own site on October 16, 2026.
A green check marks a clear edge for DeepTek or Qure.ai only where their review scores differ by at least 0.3 points or the two reviews show a plain difference. Rows with nothing published for either DeepTek or Qure.ai are left out, and time to full value for each adds up the rollout stages in its review.
Sources
- HIR review of DeepTek and HIR review of Qure.ai
- DeepTek website
- Qure.ai website
- Reddit discussions of DeepTek and Qure.ai, linked in the buyer section
- Qure.ai qXR-Detect clearance, February 26, 2026